Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00127920
Recruitment Status : Completed
First Posted : August 9, 2005
Last Update Posted : March 10, 2015
Genentech, Inc.
Information provided by (Responsible Party):
Gynecologic Oncology Associates

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2006
  Actual Study Completion Date : October 2012